MULTIPLE SYSTEM ATROPHY (MSA)
Clinical trials for MULTIPLE SYSTEM ATROPHY (MSA) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY (MSA) trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY (MSA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough trial aims to slow devastating brain disease
Disease control Recruiting nowThis study is testing whether a supplement called MSA-01 can slow down the progression of multiple system atrophy (MSA), a rare and serious brain disorder that currently has no treatment to stop it. About 140 people with MSA will take either MSA-01 or a placebo pill daily for one…
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Phase: PHASE3 • Sponsor: Tokyo University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for devastating brain disease? early test of nerve repair drug begins
Disease control Recruiting nowThis is a very early study to check if a new drug called Aleeto is safe and might help people with multiple system atrophy (MSA), a rare and serious brain disease that gets worse over time. The study will involve about 20 people with MSA and will closely monitor their health for …
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Phase: EARLY_PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists test 'Flashlight' scan to see Parkinson's brain clumps
Diagnosis Recruiting nowThis early-stage study is testing a new type of brain scan to see if it can safely and reliably detect clumps of a protein called alpha-synuclein in the brain. These protein clumps are involved in Parkinson's disease, Lewy body dementia, and multiple system atrophy. Researchers w…
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Phase: EARLY_PHASE1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated Apr 02, 2026 04:11 UTC